omniture
logo
Search
凌科药业（杭州）有限公司 Lingke Pharmaceutical
Media Room

Latest News

rss

Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Study of LNK01001 in Patients with Atopic Dermatitis

HANGZHOU, China, Feb. 28, 2022 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred...

2022-02-28 08:00 3679

Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Study of LNK01001 in Patients with Ankylosing Spondylitis

HANGZHOU, China, Jan. 19, 2022 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred...

2022-01-19 08:00 3664

Lynk Pharmaceuticals Announced First Patient Dosed in Phase II Clinical Study of LNK01001

HANGZHOU, China, Dec. 1, 2021 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred ...

2021-12-01 08:00 4105

Lynk Pharmaceuticals announced the completion of Series B financing of $50 million

HANGZHOU, China, Aug. 27, 2021 /PRNewswire/ -- Lynk Pharmaceuticals CO., LTD (hereinafter referred ...

2021-08-27 08:00 5800

Lynk Pharmaceuticals Announced First Patient Dosed in Phase I Clinical Study of Its Triple-Kinase Inhibitor LNK01002

HANGZHOU, China, Aug. 12, 2021 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred...

2021-08-12 08:00 4425

Lynk Pharmaceuticals Announced Clinical Approval in China of Its New Class I Drug LNK01003

HANGZHOU, China, June 25, 2021 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred...

2021-06-25 15:11 5066
12